Evaluation markers of systemic inflammatory response in patients with high cardiovascular risk
In the prospective study conducted during the year was estimated marker of systemic inflammatory response – a highly sensitive C- reactive protein, and analyzed its relationship with some clinical and metabolic parameters. According to the results of the results found that increased levels of markers analyzed CBP should be interpreted as a factor of poor prognosis in patients with type 2 diabetes, accompanied by an increase in the probability of occurrence of adverse cardiovascular events in total during the year. Also, elevated levels of CRP-hs more than 5 mg / l can be considered as a predictor of total cardiovascular events throughout the year in patients with type 2 diabetes, as a category of patients at high cardiovascular risk.